NT-ProBNP level in our cohort was much lower (median: 4230 pg/mL) as compared to ASCEND-HF trial 5773 pg/mL, PRIMA II trial 6350 pg/mL and Taiwan 11,530 pg/mL. The gene discussed is NPPB; the disease is hydrops fetalis.